Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
In-depth analysis of the treatment of Balversa, the primary concern is its recom···【more】
Release date：2024-08-27Recommended：513
Alpelisib effectively treats patients with HR/HER2- breast cancer harboring PIK3···【more】
Release date：2024-08-26Recommended：530
As the first PI3Kα inhibitor, Alpelisib has shown significant efficacy in the tr···【more】
Release date：2024-08-26Recommended：549
Alpelisib, approved in 2019, has a unique efficacy against PIK3CA mutant breast ···【more】
Release date：2024-08-26Recommended：568
Alpelisib is the first PI3K inhibitor specifically for PIK3CA-mutated breast can···【more】
Release date：2024-08-26Recommended：529
Alpelisib was approved by the FDA in 2019 for the treatment of breast cancer pat···【more】
Release date：2024-08-26Recommended：532
Alpelisib is the first PI3Kα inhibitor to be used in combination with fulvestran···【more】
Release date：2024-08-26Recommended：589
Balversais a new target anti-cancer star, specializing in FGFR-positive cancers,···【more】
Release date：2024-08-26Recommended：479
Balversa, an innovative anti-cancer targeted drug, accurately snipes FGFR-positi···【more】
Release date：2024-08-26Recommended：521
Balversa is an innovative targeted therapy that effectively inhibits the growth ···【more】
Release date：2024-08-26Recommended：526
Balversa, a new targeted anti-cancer drug, provides new treatment hope for patie···【more】
Release date：2024-08-26Recommended：473
Balversa is a novel targeted anti-cancer drug that inhibits the FGFR signaling p···【more】
Release date：2024-08-26Recommended：421
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
